Ardelyx, Inc.

NasdaqGM:ARDX

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🧬 Biotechnology

💊 Drugstores & Retail Pharmacies

🌿 Fertilizers

💊 Pharmaceuticals

Location

United States

Market Cap

USD 1.10 B

Share Price

USD 4.61

Avg Daily Volume

5,388,045

Change (1 day)

2.67%

Change (1 year)

-21.73%

Change (YTD)

-9.07%

Ardelyx, Inc. Accounts Payable for the year ending December 31, 2024: USD 16.00 M

Ardelyx, Inc. Accounts Payable is USD 16.00 M for the year ending December 31, 2024, a 43.65% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.

Ardelyx, Inc. Accounts Payable for the year ending December 31, 2023 was USD 11.14 M, a 2.57% change year over year.
Ardelyx, Inc. Accounts Payable for the year ending December 31, 2022 was USD 10.86 M, a 153.89% change year over year.
Ardelyx, Inc. Accounts Payable for the year ending December 31, 2021 was USD 4.28 M, a -23.98% change year over year.
Ardelyx, Inc. Accounts Payable for the year ending December 31, 2020 was USD 5.63 M, a 157.25% change year over year.

Competitors

BioMarin Pharmaceutical Inc.

USD 58.23

BMRN

+0.13 0.22%

Kyowa Kirin Co., Ltd.

USD 16.82

4151.T

+0.07 0.44%

Abbott India Limited

USD 400.70

ABBOTINDIA.NS

+1.92 0.48%

Sichuan Kelun Pharmaceutical Co., Ltd.

USD 4.58

002422.SZ

-0.05 -1.14%

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

USD 8.31

688336.SS

+0.48 6.12%

SCHOTT Pharma AG & Co. KGaA

USD 30.15

1SXP.F

-0.24 -0.78%

Livzon Pharmaceutical Group Inc.

USD 4.05

1513.HK

+0.10 2.62%

Chengdu Kanghong Pharmaceutical Group Co., Ltd

USD 4.42

002773.SZ

+0.17 3.91%

China Medical System Holdings Limited

USD 1.65

0867.HK

+0.05 3.23%

Gland Pharma Limited

USD 22.10

GLAND.NS

+0.13 0.58%

Jilin Aodong Pharmaceutical Group Co., Ltd.

USD 2.57

000623.SZ

+0.10 3.92%

China Resources Double-Crane Pharmaceutical Co.,Ltd.

USD 2.61

600062.SS

+0.01 0.35%

Beijing Aosaikang Pharmaceutical Co., Ltd.

USD 2.75

002755.SZ

+0.03 1.26%

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd

USD 1.53

603707.SS

-0.00 -0.11%

Yifan Pharmaceutical Co., Ltd.

USD 2.05

002019.SZ

+0.07 3.50%

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

USD 0.73

9989.HK

-0.03 -3.34%

Concord Biotech Limited

USD 21.37

CONCORDBIO.NS

+0.01 0.04%

China Resources Boya Bio-pharmaceutical Group Co., Ltd.

USD 3.67

300294.SZ

-0.00 -0.02%

Neuland Laboratories Limited

USD 173.76

NEULANDLAB.NS

+4.59 2.71%

Faes Farma, S.A.

USD 5.35

FAE.MC

+0.04 0.67%

Key Data

Date	Accounts Payable	Short-Term Debt	Long-Term Debt	Total Liabilities